Compare CSX Corporation (CSX) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Novavax Inc — how do they compare? CSX Corporation trades at $50.03 (market cap $92.88B), while Novavax Inc trades at $7.97 (market cap $1.30B). The key difference: CSX Corporation is far larger — about 71.4× Novavax Inc's market cap, and CSX Corporation pays a 1.12% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| CSX | NVAX | |
|---|---|---|
Market Cap | $92.88B | $1.30B |
Sector | Industrials | Health |
52-Week High | $53.21 | $11.19 |
52-Week Low | $32.05 | $6.22 |
Enterprise Value | $110.85B | $879.40M |
Dividend Yield | 1.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
